Philippine FDA Approves Johnson & Johnson (JNJ) Vaccine for Emergency Use: CNN Phil - Bloomberg
- Wall Street ends volatile week sharply higher
- Disney (DIS) Dips As Streaming Business Shows Signs of Slowing Down, Analysts 'Very Bullish' on LT Opportunity
- Airbnb (ABNB) Bookings Up 52% to Help Sales Beat, Seen as a 'Blow Out Quarter' as More Upside is Left
- DoorDash (DASH) Reports Bigger Loss and a Sales Beat, Shares Soars on Strong Guidance and Two Upgrades to 'Buy'
- Coinbase (COIN) To Add Dogecoin Trading in the Next Few Weeks
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Philippine FDA Approves Johnson & Johnson (NYSE: JNJ) Vaccine for Emergency Use: CNN Phil - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fate Therapeutics (FATE) Reports Encouraging Interim Phase 1 Data for iPSC-derived NK Cell Programs in Relapsed / Refractory Acute Myeloid Leukemia
- Heron Therapeutics (HRTX) Announces U.S. FDA Approval of ZYNRELEF for Management of Postoperative Pain for up to 72 Hours
- bluebird bio (BLUE) to Present Data from Its Severe Genetic Disease and Oncology Portfolios During the EHA2021 Virtual Congress
Create E-mail Alert Related CategoriesFDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!